Blockbuster Novartis Drug Fails Key Test Hoped to Expand Its Use to Rare Blood Vessel Disorder
Novartis’s Cosentyx failed to beat a placebo in a Phase 3 clinical trial in giant…
Blockbuster Novartis Drug Fails Key Test Hoped to Expand Its Use to Rare Blood Vessel Disorder
Novartis’s Cosentyx failed to beat a placebo in a Phase 3 clinical trial in giant cell arteritis. The antibody drug was being developed as an alternative to Roche and AbbVie drugs whose approved uses include treating this autoimmune disorder affecting blood vessels. The post Blockbuster Novartis Drug Fails Key Test Hoped to Expand Its Use…
Why HIPAA Compliance Is Both a Challenge and Opportunity for EMS Providers
From mobile documentation to emergency handoffs, EMS providers handle sensitive patient information in fast-moving environments. Understanding how HIPAA applies — and how to comply — can improve care, reduce risk, and build systemwide trust. The post Why HIPAA Compliance Is Both a Challenge and Opportunity for EMS Providers appeared first on MedCity News.
For the Sake of their Constituents, Congress Should Increase Medicare Payments and Oppose Deep Cuts to Medicaid
Drastic cuts to Medicaid and Medicare proposed by Congress will increase wait times, result in more fragmented or nonexistent care, and cause unnecessary deaths and despair. The post For the Sake of their Constituents, Congress Should Increase Medicare Payments and Oppose Deep Cuts to Medicaid appeared first on MedCity News.
Beyond Broken Links: The High Stakes of Provider Directory Accuracy in the No Surprises Era
Inaccuracies don’t just erode trust — they lead directly to surprise billing events, missed appointments, care delays, and in some cases, enforcement action. The post Beyond Broken Links: The High Stakes of Provider Directory Accuracy in the No Surprises Era appeared first on MedCity News.
Journalists Assess Health Impacts of Trump’s Megabill, Who Will Feel Them, and When
KFF Health News chief Washington correspondent Julie Rovner discussed how cuts to Medicaid in President Donald Trump’s megabill will affect Americans’ access to health care on NPR’s “Up First,” CNN’s “CNN This Morning” and WNYC’s “The Brian Lehrer Show” on July 2. Rovner also discussed U.S. domestic and global vaccine policy on WAMU’s “1A” on July…
Friday Links
Trends in cost-related non-adherence.Optum Rx reduces reauthorization requirements.Changes in insulin out-of-pocket costs over time.AI and billable hours.Value in Health to include ‘Plan Language Summaries’
From Fee-for-Service to Value-Based Care: Enhancing Outcomes in Nephrology
A systemic change from FFS to VBC would represent more than a payment model switch, but rather a holistic transition toward patient-centered healthcare that prioritizes outcomes over activity. The post From Fee-for-Service to Value-Based Care: Enhancing Outcomes in Nephrology appeared first on MedCity News.
With FDA Nod in Lung Cancer, Dizal Now Aims to Best a J&J Drug and Succeed Where Takeda Fell Short
Dizal Pharmaceutical’s Zegfrovy is now FDA approved for treating non-small cell lung cancer driven by a particular rare genetic signature. Johnson & Johnson drug Rybrevant already addresses this genetic signature as an earlier line of therapy, but Dizal executives contend their drug offers the potential for better safety and efficacy. The post With FDA Nod…
Eko Health’s AI for Cardiac Diagnoses Earns CMS Reimbursement Rate
This week, CMS established a reimbursement code for Eko Health’s AI platform, which seeks to aid clinicians in the diagnosis of heart conditions. The goal behind the technology is to help catch heart disease earlier, when it’s easier to treat, and to make high quality diagnostic care more accessible. The post Eko Health’s AI for…
States Brace for Reversal of Obamacare Coverage Gains Under Trump’s Budget Bill
Shorter enrollment periods. More paperwork. Higher premiums. The sweeping tax and spending bill pushed by President Donald Trump includes provisions that would not only reshape people’s experience with the Affordable Care Act but, according to some policy analysts, also sharply undermine the gains in health insurance coverage associated with it. The moves affect consumers and…
